Regional cerebral blood flow abnormalities in chronic solvent abusers

Psychiatry and Clinical Neurosciences

Volumn 53, Issue 3, 1999, Pages 351-356

  Okada, Shin Ichi ^a   Yamanouchi, Naoto ^a   Kodama, Kazuhiro ^a   Uchida, Yoshitaka ^b   Hirai, Shinji ^c   Sakamoto, Tadashi ^d   Noda, Shingo ^a   Komatsu, Naoya ^a   Sato, Toshio ^a  

^a CHIBA UNIVERSITY   (Japan)

^b CHIBA UNIVERSITY HOSPITAL   (Japan)

^c National Shimofusa Hospital   (Japan)

^d Chiba Municipal Hospital   (Japan)

Author keywords

Amotivational syndrome; Regional cerebral blood flow; Scale for the Assessment of Negative Symptoms; Single photon emission computed tomography; Solvent abuse

Indexed keywords

IOFETAMINE I 123; NEUROLEPTIC AGENT; SOLVENT;

ADOLESCENT; ADULT; APATHY; ARTICLE; BRAIN BLOOD FLOW; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; MALE; PREFRONTAL CORTEX; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SUBSTANCE ABUSE; SYNDROME;

ADOLESCENT; ADULT; BRAIN; BRAIN ISCHEMIA; DOMINANCE, CEREBRAL; FEMALE; HUMANS; MALE; MOTIVATION; PREFRONTAL CORTEX; PSYCHIATRIC STATUS RATING SCALES; REGIONAL BLOOD FLOW; SOCIAL ADJUSTMENT; SOLVENTS; SUBSTANCE-RELATED DISORDERS; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 0032840977     PISSN: 13231316     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-1819.1999.00557.x     Document Type: Article

References (23)

1. Fornazzari L, Wilkinson DA, Kapur BM, Carlen PL. Cerebellar, cortical and functional impairment in toluene abusers. Acta Neurol. Scand. 1983; 67: 319-329.
2. Hormes JT, Filley CM, Rosenberg NL. Neurologic sequelae of chronic solvent vapor abuse. Neurology 1986; 36: 698-702.
3. Rosenberg NL, Kleinschmidt-DeMasters BK, Davis KA, Dreisbach JN, Hormes JT, Filley CM. Toluene abuse causes diffuse central nervous system white matter changes. Ann. Neurol. 1988; 23: 611-614.
4. Filley CM, Heaton RK, Rosenberg NL. White matter dementia in chronic toluene abuse. Neurology 1990; 40: 532-534.
5. Yamanouchi N, Okada S, Kodama K et al. White matter changes caused by chronic solvent abuse. AJNR Am. J. Neuroradiol. 1995; 16: 1643-1649.
6. Channer KS, Stanley S. Persistent visual hallucinations secondary to chronic solvent encephalopathy: case report and review of the literature. J. Neurol. Neurosurg. Psychiatry 1983; 46: 83-86.
7. Fukui S, Wada K, Iyo M. Clinical characteristics of the recent organic solvent dependents who visited psychiatric facilities. J. Mental Health 1989; 35: 107-131 (in Japanese with English abstract).
8. Kato N. Drug dependence: Overview from biopsychosocial aspects. Shinkoh Igaku Shuppan, Tokyo 1993; 105-111 (in Japanese).
9. McGlothlin WH, West LJ. The marijuana problem: an overview. Am. J. Psychiatry 1968; 125: 370-378.
10. Oda S. Clinical aspects of organic solvent dependence, (translated title) In: Ohara K and Tadokoro S (eds), Alcohol and Drug Dependence. Kanehara Shuppan, Tokyo, 1984; 386-393 (in Japanese).
11. Ohta H, Komibuchi T, Nishino I, Enomoto Y, Miyata M. Brain perfusion abnormalities in a thinner and amphetamine abuser detected by I-123 IMP scintigraphy. Ann. Nucl. Med. 1992; 6: 273-275.
12. Hirai H, Ikeuchi Y, Terashima Y, Sakuma K, Yoshikawa K. MRI of chronic toluene intoxication. Clin. Neurol. 1993; 33: 552-555 (in Japanese with English abstract).
13. Imai K, Mizukami K, Shiraishi H et al. A case of chronic toluene intoxication with various central nervous system symptoms; special reference with MR, SPECT, and PET findings. Seishinigaku 1994; 36: 943-948 (in Japanese with English abstract).
14. Andreasen NC. Negative symptoms in schizophrenia: definition and reliability. Arch. Gen. Psychiatry 1982; 39: 784-788.
15. Kupfer DJ, Detre T, Koral J, Fajans P. A comment on the amotivational syndrome in marijuana smokers. Am. J. Psychiatry 1973; 130: 1319-1322.
16. Kolansky H, Moore WT. Toxic effects of chronic marijuana use. JAMA 1972; 222: 35-41.
17. Arlien-S, Søborg P, Henriksen L, Gade A, Gyldensted C, Paulson OB. Cerebral blood flow in chronic toxic encephalopathy in house painters exposed to organic solvents. Acta Neurol. Scand. 1982; 66: 34-41.
18. Hagstadius S, Risberg J. Regional cerebral blood flow in subjects occupationally exposed to organic solvents. In: Gilioli, R, Cassitto, M, For V (eds), Neurobehavioral Methods in Occupational Health. Pergamon Press, Oxford, 1983; 211-217.
19. Callender TJ, Morrow L, Subramanian K, Duhon D, Ristow M. Three-dimensional brain metabolic imaging in patients with toxic encephalopathy. Environ. Res. 1993; 60: 295-319.
20. Parker MJ, Tarlow MJ, Anderson JM. Glue sniffing and cerebral infarction. Arch. Dis. Child. 1984; 59: 675-677.
21. Escobar A, Aruffo C. Chronic thinner intoxication: clinico-pathologic report of a human case. J. Neurol. Neurosurg. Psychiatry 1980; 43: 986-994.
22. Fukui K, Utsumi H, Tamada Y, Nakajima Y, Ibata Y. Selective increase in astrocytic elements in the rat dentate gyrus after chronic toluene exposure studied by GFAP immunocytochemistry and electron microscopy. Neurosci. Lett. 1996; 203: 85-88.
23. Utsumi H. Effects of organic solvent on the expression of Fos protein in the mouse forebrain. J. Kyoto Prefectural University of Medicine 1995; 104: 1391-1402 (in Japanese with English abstract).